annual cash & cash equivalents:
$306.76M+$127.96M(+71.57%)Summary
- As of today (June 11, 2025), HAE annual cash & cash equivalents is $306.76 million, with the most recent change of +$127.96 million (+71.57%) on March 29, 2025.
- During the last 3 years, HAE annual cash & cash equivalents has risen by +$47.27 million (+18.21%).
- HAE annual cash & cash equivalents is now at all-time high.
Performance
HAE Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$306.76M-$14.08M(-4.39%)Summary
- As of today (June 11, 2025), HAE quarterly cash & cash equivalents is $306.76 million, with the most recent change of -$14.08 million (-4.39%) on March 1, 2025.
- Over the past year, HAE quarterly cash & cash equivalents has increased by +$127.96 million (+71.57%).
- HAE quarterly cash & cash equivalents is now -12.60% below its all-time high of $351.00 million, reached on September 30, 2023.
Performance
HAE quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
HAE Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +71.6% | +71.6% |
| 3 y3 years | +18.2% | +18.2% |
| 5 y5 years | +123.4% | +123.4% |
HAE Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +71.6% | -12.6% | +71.6% |
| 5 y | 5-year | at high | +123.4% | -12.6% | +123.4% |
| alltime | all time | at high | >+9999.0% | -12.6% | >+9999.0% |
HAE Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | $306.76M(+71.6%) | - |
| Mar 2025 | - | $306.76M(-4.4%) |
| Dec 2024 | - | $320.85M(+7.2%) |
| Sep 2024 | - | $299.28M(-13.1%) |
| Jun 2024 | - | $344.43M(+92.6%) |
| Mar 2024 | $178.80M(-37.1%) | - |
| Mar 2024 | - | $178.80M(-7.8%) |
| Dec 2023 | - | $193.98M(-44.7%) |
| Sep 2023 | - | $351.00M(+22.8%) |
| Jun 2023 | - | $285.72M(+0.4%) |
| Mar 2023 | $284.47M(+9.6%) | $284.47M(+27.0%) |
| Dec 2022 | - | $224.00M(-7.1%) |
| Sep 2022 | - | $241.20M(+12.2%) |
| Jun 2022 | - | $214.95M(-17.2%) |
| Mar 2022 | $259.50M(+34.9%) | $259.50M(+9.5%) |
| Dec 2021 | - | $236.88M(+23.1%) |
| Sep 2021 | - | $192.42M(+10.9%) |
| Jun 2021 | - | $173.46M(-9.8%) |
| Mar 2021 | $192.31M(+40.1%) | $192.31M(+1.7%) |
| Dec 2020 | - | $189.00M(-32.3%) |
| Sep 2020 | - | $279.17M(+1.2%) |
| Jun 2020 | - | $275.73M(+100.8%) |
| Mar 2020 | $137.31M(-18.9%) | $137.31M(+8.6%) |
| Dec 2019 | - | $126.42M(+12.8%) |
| Sep 2019 | - | $112.03M(-41.1%) |
| Jun 2019 | - | $190.23M(+12.3%) |
| Mar 2019 | $169.35M(-6.0%) | $169.35M(+9.3%) |
| Dec 2018 | - | $154.87M(-22.5%) |
| Sep 2018 | - | $199.76M(+4.0%) |
| Jun 2018 | - | $192.11M(+6.6%) |
| Mar 2018 | $180.17M(+29.1%) | $180.17M(-28.4%) |
| Dec 2017 | - | $251.59M(+23.6%) |
| Sep 2017 | - | $203.62M(+18.6%) |
| Jun 2017 | - | $171.74M(+23.1%) |
| Mar 2017 | $139.56M(+21.2%) | $139.56M(+7.7%) |
| Dec 2016 | - | $129.64M(-6.6%) |
| Sep 2016 | - | $138.87M(+17.4%) |
| Jun 2016 | - | $118.25M(+2.7%) |
| Mar 2016 | $115.12M(-28.3%) | $115.12M(+9.5%) |
| Dec 2015 | - | $105.17M(+4.9%) |
| Sep 2015 | - | $100.25M(-10.7%) |
| Jun 2015 | - | $112.20M(-30.2%) |
| Mar 2015 | $160.66M(-16.5%) | $160.66M(+28.3%) |
| Dec 2014 | - | $125.20M(-3.7%) |
| Sep 2014 | - | $129.97M(-7.1%) |
| Jun 2014 | - | $139.94M(-27.3%) |
| Mar 2014 | $192.47M(+7.5%) | $192.47M(+8.2%) |
| Dec 2013 | - | $177.85M(+11.7%) |
| Sep 2013 | - | $159.15M(-4.3%) |
| Jun 2013 | - | $166.33M(-7.1%) |
| Mar 2013 | $179.12M(-21.7%) | $179.12M(-7.3%) |
| Dec 2012 | - | $193.18M(+3.3%) |
| Sep 2012 | - | $187.05M(-20.8%) |
| Jun 2012 | - | $236.05M(+3.1%) |
| Mar 2012 | $228.86M(+16.3%) | $228.86M(+11.4%) |
| Dec 2011 | - | $205.37M(+12.0%) |
| Sep 2011 | - | $183.42M(-15.4%) |
| Jun 2011 | - | $216.89M(+10.3%) |
| Mar 2011 | $196.71M(+39.0%) | $196.71M(+16.0%) |
| Dec 2010 | - | $169.54M(+47.4%) |
| Sep 2010 | - | $115.05M(+37.8%) |
| Jun 2010 | - | $83.47M(-41.0%) |
| Mar 2010 | $141.56M(-9.7%) | $141.56M(-16.2%) |
| Dec 2009 | - | $168.99M(-5.2%) |
| Sep 2009 | - | $178.32M(+2.6%) |
| Jun 2009 | - | $173.82M(+10.9%) |
| Mar 2009 | $156.72M | $156.72M(+25.1%) |
| Dec 2008 | - | $125.33M(+12.6%) |
| Sep 2008 | - | $111.33M(-7.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2008 | - | $120.29M(-9.9%) |
| Mar 2008 | $133.55M(-41.7%) | $133.55M(+14.3%) |
| Dec 2007 | - | $116.86M(-24.6%) |
| Sep 2007 | - | $154.98M(-28.3%) |
| Jun 2007 | - | $216.06M(-5.7%) |
| Mar 2007 | $229.23M(-8.6%) | $229.23M(+0.7%) |
| Dec 2006 | - | $227.71M(-6.0%) |
| Sep 2006 | - | $242.20M(-6.9%) |
| Jun 2006 | - | $260.03M(+3.7%) |
| Mar 2006 | $250.67M(+34.9%) | $250.67M(+9.3%) |
| Dec 2005 | - | $229.35M(+9.2%) |
| Sep 2005 | - | $209.98M(+6.0%) |
| Jun 2005 | - | $198.07M(+6.6%) |
| Mar 2005 | $185.81M(+133.8%) | $185.81M(+15.9%) |
| Dec 2004 | - | $160.28M(+11.4%) |
| Sep 2004 | - | $143.83M(+10.3%) |
| Jun 2004 | - | $130.36M(+64.0%) |
| Mar 2004 | $79.47M(+59.3%) | $79.47M(-18.2%) |
| Dec 2003 | - | $97.18M(+45.5%) |
| Sep 2003 | - | $66.77M(+33.0%) |
| Jun 2003 | - | $50.19M(+0.6%) |
| Mar 2003 | $49.88M(+42.9%) | $49.88M(+0.4%) |
| Dec 2002 | - | $49.67M(+13.9%) |
| Sep 2002 | - | $43.62M(+3.8%) |
| Jun 2002 | - | $42.01M(+20.3%) |
| Mar 2002 | $34.91M(-15.8%) | $34.91M(-34.0%) |
| Dec 2001 | - | $52.90M(-8.6%) |
| Sep 2001 | - | $57.85M(+41.2%) |
| Jun 2001 | - | $40.96M(-1.2%) |
| Mar 2001 | $41.44M(+59.9%) | $41.44M(-30.0%) |
| Dec 2000 | - | $59.21M(+53.3%) |
| Sep 2000 | - | $38.62M(-26.0%) |
| Jun 2000 | - | $52.20M(+101.4%) |
| Mar 2000 | $25.91M(-54.0%) | $25.91M(-44.3%) |
| Dec 1999 | - | $46.50M(-17.3%) |
| Sep 1999 | - | $56.20M(+5.4%) |
| Jun 1999 | - | $53.30M(-5.3%) |
| Mar 1999 | $56.30M(+158.3%) | $56.30M(+33.1%) |
| Dec 1998 | - | $42.30M(+13.7%) |
| Sep 1998 | - | $37.20M(+53.1%) |
| Jun 1998 | - | $24.30M(+11.5%) |
| Mar 1998 | $21.80M(+162.7%) | $21.80M(+198.6%) |
| Dec 1997 | - | $7.30M(+10.6%) |
| Sep 1997 | - | $6.60M(+17.9%) |
| Jun 1997 | - | $5.60M(-32.5%) |
| Mar 1997 | $8.30M(-38.1%) | $8.30M(-50.0%) |
| Dec 1996 | - | $16.60M(+25.8%) |
| Sep 1996 | - | $13.20M(+21.1%) |
| Jun 1996 | - | $10.90M(-18.7%) |
| Mar 1996 | $13.40M(+219.0%) | $13.40M(-3.6%) |
| Dec 1995 | - | $13.90M(+65.5%) |
| Sep 1995 | - | $8.40M(+127.0%) |
| Jun 1995 | - | $3.70M(-11.9%) |
| Mar 1995 | $4.20M(-74.1%) | $4.20M(+13.5%) |
| Dec 1994 | - | $3.70M(-56.0%) |
| Sep 1994 | - | $8.40M(+33.3%) |
| Jun 1994 | - | $6.30M(-61.1%) |
| Mar 1994 | $16.20M(+57.3%) | $16.20M(+17.4%) |
| Dec 1993 | - | $13.80M(+34.0%) |
| Sep 1993 | - | $10.30M(+134.1%) |
| Jun 1993 | - | $4.40M(-57.3%) |
| Mar 1993 | $10.30M(+255.2%) | $10.30M(+37.3%) |
| Dec 1992 | - | $7.50M(+240.9%) |
| Sep 1992 | - | $2.20M(+144.4%) |
| Jun 1992 | - | $900.00K(-69.0%) |
| Mar 1992 | $2.90M | $2.90M(+866.7%) |
| Dec 1991 | - | $300.00K(-57.1%) |
| Sep 1991 | - | $700.00K(-41.7%) |
| Jun 1991 | - | $1.20M |
FAQ
- What is Haemonetics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Haemonetics?
- What is Haemonetics annual cash & cash equivalents year-on-year change?
- What is Haemonetics quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Haemonetics?
- What is Haemonetics quarterly cash & cash equivalents year-on-year change?
What is Haemonetics annual cash & cash equivalents?
The current annual cash & cash equivalents of HAE is $306.76M
What is the all time high annual cash & cash equivalents for Haemonetics?
Haemonetics all-time high annual cash & cash equivalents is $306.76M
What is Haemonetics annual cash & cash equivalents year-on-year change?
Over the past year, HAE annual cash & cash equivalents has changed by +$127.96M (+71.57%)
What is Haemonetics quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of HAE is $306.76M
What is the all time high quarterly cash & cash equivalents for Haemonetics?
Haemonetics all-time high quarterly cash & cash equivalents is $351.00M
What is Haemonetics quarterly cash & cash equivalents year-on-year change?
Over the past year, HAE quarterly cash & cash equivalents has changed by +$127.96M (+71.57%)